ArticleNature biotechnology2016

Targeted gene addition in human CD34(+) hematopoietic cells for correction of X-linked chronic granulomatous disease.

Suk See De Ravin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.